Rebif Pregnancy Registry.
Phase of Trial: Phase IV
Latest Information Update: 23 Aug 2011
At a glance
- Drugs Interferon beta-1b (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- Sponsors EMD Serono; Serono SA
- 01 Jun 2010 Actual end date changed from 1 Apr 2008 to 1 Feb 2008 as reported by ClinicalTrials.gov.
- 01 Jun 2010 Additional lead trial investigator (Dan Mikol, MD) identified as reported by ClinicalTrials.gov.
- 01 Jun 2010 Actual number of patients changed from 300 to 36 as reported by ClinicalTrials.gov.